| 000 | 01524 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513083915.0 | ||
| 264 | 0 | _c19960209 | |
| 008 | 199602s 0 0 eng d | ||
| 022 | _a0272-6386 | ||
| 024 | 7 |
_a10.1016/s0272-6386(96)90046-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHenrich, W L | |
| 245 | 0 | 0 |
_aAnalgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. _h[electronic resource] |
| 260 |
_bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _cJan 1996 |
||
| 300 |
_a162-5 p. _bdigital |
||
| 500 | _aPublication Type: Guideline; Journal Article; Practice Guideline | ||
| 650 | 0 | 4 |
_aAcetaminophen _xadverse effects |
| 650 | 0 | 4 |
_aAnalgesics _xadverse effects |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 |
_aAspirin _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
| 700 | 1 | _aAgodoa, L E | |
| 700 | 1 | _aBarrett, B | |
| 700 | 1 | _aBennett, W M | |
| 700 | 1 | _aBlantz, R C | |
| 700 | 1 | _aBuckalew, V M | |
| 700 | 1 | _aD'Agati, V D | |
| 700 | 1 | _aDeBroe, M E | |
| 700 | 1 | _aDuggin, G G | |
| 700 | 1 | _aEknoyan, G | |
| 773 | 0 |
_tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _gvol. 27 _gno. 1 _gp. 162-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0272-6386(96)90046-3 _zAvailable from publisher's website |
| 999 |
_c8545231 _d8545231 |
||